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Summary 
Invariant chain (Ii),  which associates with major histocompatibility complex (MHC) class II 
molecules in the endoplasmic reticulum, contains a targeting signal for transport to intracellular 
vesicles in the endocytic pathway. The characteristics of the target vesicles and the relationship 
between Ii structure and class II localization in distinct endosomal subcompartments have not 
been well defined. We demonstrate here that in transiently transfected COS ceils expressing high 
levels of the p31 or p41 forms of Ii, uncleaved Ii is transported to and accumulates in transferrin- 
accessible (early) endosomes. Coexpressed MHC class II is also found in this same compartment. 
These early endosomes show altered morphology and a slower rate of content movement to 
later parts of the endocytic pathway. At more moderate levels of Ii expression,  or after removal 
of a highly conserved region in the cytoplasmic tail of Ii, coexpressed class II molecules are found 
primarily in vesicles with the characteristics  of late endosomes/prelysosomes. The Ii chains in 
these late endocytic vesicles have undergone proteolytic cleavage in the lumenal region postulated 
to control MHC class II peptide binding. These data indicate that the association  of class II 
with Ii results in initial movement to early endosomes. At high levels of Ii expression,  egress 
to later endocytic compartments is delayed and class II-Ii complexes accumulate together with 
endocytosed material. At lower levels of Ii expression,  class II-Ii complexes are found primarily 
in late endosomes/prelysosomes. These data provide evidence that the route of class II transport 
to the site of antigen processing and loading involves movement through early endosomes to 
late endosomes/prelysosomes. Our results also reveal an unexpected ability of intact Ii to modify 
the structure and function of the early endosomal compartment, which may play a role in regulating 
this processing pathway. 
T 
he function of MHC class II molecules is to present pep- 
tides to  the ot/B receptor of CD4 + T  lymphocytes. 
MHC class II molecules primarily present peptides derived 
from proteins that access the endocytic pathway (1), whether 
by fluid phase uptake, receptor-mediated uptake, recycling of 
endogenously synthesized proteins from the plasma mem- 
brane, or, in the case of cytosolic proteins, perhaps autophagy 
(2). Previous functional data supporting this conclusion have 
recently been bolstered by sequence analysis of peptides ehted 
from purified MHC class II molecules (3-6). Various methods 
have been used to study the intracellular maturation and trans- 
port of MHC class II molecules and to examine the location 
and biochemical events involved in processing such proteins 
into peptides suitable for binding to MHC class II molecules. 
The bulk of available data indicate that MHC class II-pep- 
tide  ass6ciation  largely  takes  place  within  the  endocytic 
pathway itself (2,  7-10).  This latter model is directly sup- 
ported by the observation that newly synthesized MHC class 
II molecules undergo a conformational alteration character- 
istic of peptide binding in an intracdlular, post-Golgi com- 
partment (11-13). 
Subcellular fractionation has demonstrated that in B cells 
and B cell tumors, MHC class II molecules are present in 
light vesicular structures derived from early and/or late en- 
dosomes (14). Immunodectronmicroscopy  of mouse perito- 
neal macrophages and human B cells has revealed some class 
II-containing vesicular structures with the lucent appearance 
of early endosomes (7, 14), and others with the multivesic- 
ular appearance of carrier vesicles, late endosomes, or prelyso- 
somes (9, 14). In certain nonlymphoid  ceils, the distribution 
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lysosomal pathway (15). 
What controls MHC class  II movement into,  through, 
and out of the various vesicular subcompartments  of this 
pathway? A  nonpolymorphic  type II membrane glycopro- 
rein (16) termed the invariant  chain (Ii) 1 (17) appears to be 
the key to the control of MHC class II availability for pep- 
tide binding and intracellular localization. There are several 
distinct forms ofli, termed p31, p33, p41, and p43, that arise 
from a combination of alternative translation initiation (p31 
vs. p33, p41 vs. p43) and alternative splicing that results in 
the presence or absence of a lumenal subdomain (p41, p43 
vs. p31, p33) (18-20). These various forms of Ii associate with 
newly synthesized MHC class II o~ and fl chains in the en- 
doplasmic reticulum (ER) (21, 22), possibly as a trimeric core 
on which three odfl dimers assemble (23). Ii seems to have 
two major roles in  this early stage of class II biosynthesis 
and transport.  First, intact Ii inhibits stable peptide binding 
to MHC dass II molecules (11, 24, 25). Because Ii assembles 
with the MHC dass II c~ and fl chains rapidly after import 
into  the  ER,  this  may  constitute  a  major  mechanism 
precluding effective peptide binding in this early postsynthetic 
phase of the class II pathway, providing "empty" MHC class 
II molecules suitable for peptide capture elsewhere in the cell. 
Second, Ii also acts as a specialized chaperone to facilitate the 
export  of dass II molecules from the ER,  most likely by 
preventing  retention  by resident  proteins  (26-28). 
Recent studies have shown that Ii contains a signal in the 
NH2-terminal  30 residue cytoplasmic tail  that  targets  this 
protein to an endocytic compartment  (29, 30), and that  Ii 
coexpression leads to intraceUular localization of MHC class 
II in a vesicular pattern  (10,  30).  In transfected CV1 cells, 
the amount of Ii protein increases  with time.  At relatively 
low protein levels, Ii was observed to sort to small endosomes, 
whereas at later times, when Ii expression was greater, a co- 
hort of large vesicular structures was seen (Bakke, O.,  and 
B. Dobberstein, unpublished observations). We report here 
immunofluorescence  studies that  characterize  the majority 
of these macrovesicular  structures as modified early endosomes 
whose rate of transfer  of lumenal  and membrane contents 
to later endocytic compartments is markedly slowed by the 
presence of high levels ofli. Class II and Ii can also be found 
in later endocytic locations.  The Ii in the early endosomes 
is largely intact, whereas that accumulating in late endosomes 
has undergone lumenal cleavage. These observations suggest 
that Ii initially directs class II to early endosomes from which 
the dass II-Ii complexes transit to late endosomes/prelysosomes 
where the class II binding site becomes available. The docu- 
mentation of the novel capacity of intact Ii to alter early en- 
dosome structure and function, and of these patterns of class 
II movement and co-ordinate Ii cleavage, provide new insight 
into  the class  II antigen  presentation  pathway. 
Materiah and Methods 
Expression Plasmids and Transfection.  All experiments were per- 
formed  with  COS  7.2  cells (31), which  were  maintained  in 
DMEM/10% FCS. For transient expression, a modified procedure 
from Lopata et al. (32) was used, as previously  described  (26). Briefly, 
COS 7.2 ceils plated at 106 per 25 cm  2 tissue culture  flask were 
washed twice with DMEM/10 mM Hepes. Ceils were then in- 
cubated in 3 ml DMEM/10 mM Hepes containing  400/tg/ml 
DEAl/dextran,  100/zM chloroquine  and DNA (1 /zg of each 
plasmid encoding Ac~  b [33] and Aft  b [33], 4 #g of plasmid en- 
coding mlip31 (34), mIip41 (P. Jones, unpublished data), hlip31 
(29),  hIip31A11 (29), hIip31A20  (29),  or human  lamp-1 (35). 
After 4 h at 37~  in 10% CO2, the cells were treated with 10% 
DMSO in PBS for 2 min at room temperature, and were then in- 
cubated overnight in DMEM/10% FCS. Transfected  cells were tryp- 
sinized and plated on coverslips pretreated with poly-L-lysine. 24 h 
later, ceils were processed for immunofluorescence. 
Indirect Iramunofluorescenc~  Transiently transfected COS 7.2 cells 
were fixed in 4% paraformaldehyde for 15 min at room tempera- 
ture. Fixed ceils were treated with 0.1 M glycine for 10 min, and 
were then permeabilized for 15 min with PBS containing  0.2% 
saponin and 2.5% FCS. CeLls  were incubated at room temperature 
for 15 min with primary antibodies (see figure legends). After three 
washes with PBS, cells were incubated with FITC, rhodamine, or 
Texas red conjugated secondary antibodies for 15 min at room tem- 
perature,  washed, and mounted on slides with Fluor Save  TM re- 
agent (Calbiochem Novabiochem Corp., LaJolla, CA). Ceils were 
analyzed using  a photomicroscope  (Axiophot;  Carl  Zeiss, Inc., 
Thomwood, NY) equipped with appropriate filters to gate red and 
green fluorescence. Images obtained with a  x 100 objective were 
captured with a video camera (model C2400-~8 SI~ Hamamatsu, 
Inc., Hamamatsu  City, Japan),  were digitally processed with an 
image processor (model DVS-3000; Hamamatsu,  Inc.) and were 
then transferred to a computer (Macintosh II; Apple Computer, 
Inc., Cupertino, CA). Using the Adobe Photoshop program (Adobe 
Systems, Inc., Mountain View, CA), the eight-bit grey scale images 
were  changed  into  eight-bit  red  or green  images  and  printed 
separately or superimposed using a Mavigraph printer (Sony Corp., 
Montvale, NJ). For Fig. 1 only, images were obtained using a Con- 
focal Laser Scanning System attachment (Bio-Rad/Analytical Instr. 
Group,  Cambridge,  MA) with  the Axiophot photomieroscope 
system. The image planes chosen for the figures in this paper were 
selected to emphasize intraceilular compartments,  and deempha- 
size surface protein  staining. 
Labeling with Endocytic Markers.  To label early endosomes, ceils 
were incubated for 45 min at 37"C in PBS containing  20/~g/ml 
of iron saturated transferrin (Sigma Immunochemicalg  St. Louis, 
MO).  Cells  were  then  washed,  fixed,  and  processed for  im- 
munofluorescence. To prehbd lysosomes, cells were incubated for 
6-8 h at 37~  in medium containing  1 mg/ml tetramethyl rhoda- 
mine isothiocyanate (TRI'I'C)-OVA.  Ceils were then washed and 
chased for 24 h in normal  medium  at 37~ 
The kinetics of accumulation of endocytic marker in lysosomes 
was studied by monitoring  the appearance of FITC-OVA in lyso- 
somes prehbeled with TRITC-OVA as described above. Cells were 
incubated in 1 mg/ml FITC-OVA for 1 h at 37~  washed and 
chased for 1, 6, and 24 h. 
1  Abbreviations used in this paper: ER, endoplasmic reticulum; GC, Golgi 
complex; h, human; Ii, invariant chain; m, mouse. 
Results 
Ii Determines the Intracelhlar Distribution  of MHC Class II 
Molecules  in  Transfected COS  Cells.  Previous  studies  have 
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tail necessary for targeting to and accumulation in incom- 
pletely characterized endosomal vesicles (29, 30). The human 
Ii p31 chain can alter the intracellular distribution of coex- 
pressed human dass II o~/B dimers in human fibroblasts (10, 
30).  We examined additional forms and species variants of 
Ii to determine whether they showed a similar pattern of lo- 
calization when expressed alone or with mouse class II pro- 
teins in monkey ceils. 
When analyzed with the anti-Ii cytoplasmic tail antibody 
VIC-Y1, transfected COS cells expressing human (h) Iip31 
showed staining of the nuclear envelope, ER, and Golgi com- 
plex (GC), as well as very strong staining of central vesicular 
structures (Fig.  1 A).  These data are consistent with mor- 
phological and biochemical studies showing that only a por- 
tion of the Ii molecules expressed in the absence of MHC 
class  II progress through the GC (23,  29,  30).  Using the 
present fixation conditions, staining with the anti-Ii lumenal- 
region  specific antibody  LN2  primarily  showed vesicular 
staining, as previously reported (29) (Fig. 1 B). The human 
Ii-containing vesicles varied in size and distribution among 
individual cells in even a single transfection, ranging from 
large (5-10/z) and sometimes perinuclear (Fig. 1, A  and B) 
to small ('~1/~)  and widely distributed (data not shown). 
The proportion of cells with large vesicles increased as more 
DNA was used for transfection or the time after transfection 
was lengthened, both of which increase the total amount of 
Ii expression. A similar intracellular staining pattern was ob- 
served with either mouse (m) Iip31 (data not shown) or mlip41 
(Fig.  1 F), indicating that the localization of Ii to vesicular 
structures is not a unique property of the human molecule 
or of the p31 form of the protein. 
Coexpression of Ac~Al3 dimers with Ii led to a dramatic 
change in class II localization. Intracellular staining of cells 
in which Ac~AB directs were expressed alone showed strong 
signals primarily in the ER and GC, with little vesicular lo- 
calization (Fig.  1 C). Surface class  II expression could also 
be observed as expected (data not shown). Coexpression of 
Ii altered this pattern. Less staining was seen in the ER and 
a substantial amount of MHC  class  II colocalized in large 
vesicles with human Iip31 (Fig. 1, D  and E), as well as ap- 
pearing on the plasma membrane (data not shown). A vesic- 
ular distribution of MHC class II was also seen with mouse 
Iip41 coexpression, but in this case, small, widely dispersed 
vesicles were seen (Fig. 1, G  and H). The alteration of class 
II steady state localization from exocytic compartments to 
vesicular structures upon coexpression with Ii is consistent 
with the results of Lotteau et al.  (30) and Lamb et al. (10) 
obtained using human Ii, and provide the first demonstra- 
tion that expression of the p41 form of Ii results in an intra- 
cellular  distribution  of class  II  similar  to  that  previously 
reported for the p31 form. The number and size of large vesicles 
stained with anti-Ii antibody declined in some cases when 
dass II-encoding plasmids were added to Ii transfections. Meta- 
bolic labeling experiments (data not shown) suggest that this 
may not be due solely to plasmid competition and a reduc- 
tion in absolute Ii protein levels, implying that a high level 
of free (non-cff~ complexed) Ii may be necessary for the ap- 
pearance of the large vesicles.  This apparent dependence on 
free Ii for macrosome formation may explain the differences 
observed in cells coexpressing class II with human Iip31 vs. 
mouse Iip41, as the former achieves higher levels of expres- 
sion in the COS system than the latter (data not shown). 
Active Generation of a Unique Set of Macrocytic Vesicles after 
Expression of Intact Ii.  Macrosomes were not seen after trans- 
fection of MHC class II plasmids alone (Fig. 1 C), nor after 
transfection of a variety of plasmids encoding various type 
I integral membrane proteins (e.g., CD4, CDS, MHC class 
I; data not shown). Because these latter proteins are not sdec- 
tivdy targeted to the endosomal/lysosomal pathway, we also 
expressed in COS cells human lamp-l, a lysosomal membrane 
protein that when highly expressed, trafiics through the early 
and late endocytic compartments (35). Only small- to medium- 
size ('~1/~), widely dispersed vesicles were seen in cells trans- 
fected with a plasmid encoding human lamp-1 (Fig. 2 A), 
the same staining pattern seen for endogenous simian lamp-1 
(Fig. 2 B). Thus, mere overexpression of endosomally tar- 
geted  proteins  in  the  COS  transfection  system does  not 
nonspecifically result in macrosome formation. Furthermore, 
transfection of truncated cDNAs that encoded Ii lacking the 
endosomal targeting signal in the cytoplasmic tail (hIip31A20), 
although producing as much Ii protein as the plasmid en- 
coding intact Ii, did not result in the visualization of macro- 
somal structures (data not shown). Thus, Ii macrosomes are 
specifically detected in calls expressing intact Ii. 
The macrosomal staining pattern could be due either to 
the accumulation of Ii in a preexisting set of large vesicular 
structures, now made detectable by staining for Ii, or could 
reflect  the creation of a new, previously absent cohort  of 
vesicles.  We therefore examined COS cells transfected with 
plasmids encoding intact Ii or control plasmids for the pres- 
ence of macrovesicular structures using methods that did not 
rely on detection of Ii itself. Cells exposed to high concen- 
trations of fluid phase endocytic tracers such as FITC-OVA 
or TRITC-OVA showed distinct patterns of tracer accumu- 
lation, depending on the presence or absence of Ii. Cells lacking 
Ii show numerous small dispersed vesicles (Fig. 3 A), whereas 
cells expressing Ii had the tracer in macrosomes (Fig. 3 B). 
Phase contrast observation revealed that cells without Ii did 
not have a significant number of large vesicular/vacuolar struc- 
tures, whereas cells expressing Ii contained numerous large 
lucent vesicles in the perinuclear region (data not shown). 
Acridine orange staining showed that cells lacking Ii had a 
relatively tight duster of small vesicles staining red with this 
dye, indicating their acidic nature, whereas those expressing 
Ii had large acidic vesicles corresponding in size and location 
to the macrosomes revealed by staining for Ii (data not shown). 
These observations indicate that macrosomes do not preexist 
in COS cells, but rather they are actively generated by the 
presence of high levels  of Ii and are part of the endocytic 
pathway. 
Most Ii Macrosoraes Are Altered Early Endosoraes.  There 
is general consensus that the endocytic pathway can be sub- 
divided into at least three major compartments: early endo- 
585  Romagnoli et al. 586  Ii and MHC Class II Transport into Early and Late Endocytic Compartments Figure 2.  Immunofluorescence  staining of human lamp-1 (A) in transfected COS 7.2 cens. The human protein was specifically  detected with the 
mAb HSG11 (41). The staining pattern was compared with endogenous lamp-1 (B) detected with the mAb BB6 (35) in mock-transfected  COS cells. 
Figure  3.  Invariant  chain-independent visualization of Ii-macrosomes. 48 h after transfection COS 7.2 cells expressing  AotbA/5  ~ (A) or hlip31 (B) 
were examined after FITC-OVA uptake. Cens were pulsed for 1 h with FITC-OVA (1 mg/ml), washed, and the internalized marker was chased for 
1 h at 37~  Cells were then fixed and analyzed. 
somes, late endosomes/prelysosomes, and lysosomes (42, 43). 
Ii-transfected COS cells stained with antibody to ot adaptin 
present in dathrin-coated vesicles trafficking to early endo- 
somes,  showed a pattern distinct from and nonoverlapping 
with that of Ii, which did not correspond to the macrosome 
pattern (data not shown).  However, when transfected COS 
cells expressing  hli  were incubated  for 30 min  with  iron- 
saturated human transferrin, extensive colocalization of trans- 
ferrin and Ii in macrosomes was observed (Fig. 4, A  and B). 
The macrosome-localized transferrin could be chased out com- 
pletely within 20 min (Fig. 4, C and D). In addition, a mAb 
to  an  epitope  generated  by  the  pH-dependent  change  of 
influenza hemagglutinin conformation in the acidic environ- 
ment of (early) endosomes (45) demonstrated the presence 
of recently internalized virus in the macrosomes (Fig. 5). In 
some cells, a minority of macrosomes was observed that failed 
to show transferrin accumulation (data not shown), suggesting 
that the effects on Ii on endosomal structure were not confined 
solely to the early sorting endosome. Nevertheless, these data 
strongly  suggest  that  most  macrosomes  correspond  to  a 
modification  of the early endocytic compartment. 
We also stained the Ii transfected cells with anti-'y adaptin 
antibodies  to identify the trans-Golgi network  (TGN)  and 
with  anti-CI-M6PR  antibodies  to  identify the  TGN  and 
Figure  1.  Localization of Ii, and MHC class II or//5 dimers in COS 7.2 cells transfected  with plasmids encoding hlip31 (A and B); AotbA/~ (C); 
hlip31 and Ao~bA~ (D and E); mlip41 (F); mlip41 and AotbA/3~ (G and H). Class II molecules were stained with the mAb M5/114 (36) (C and 
E) or with the mAb Y3P (37) (H); hlip31 was stained with the mAb VIC-Y1 (38) (A and D) or LN2 (39) (/3). mlip41 (F and G) was detected with 
the mAb In-1 (40). FITC-hbded second Abs against mouse or rat IgG were used. For double-staining (D, E, and G,/4) TKITC-labeled Abs against 
mouse IgG were used in D and G, and FITC-labeled antibodies against rat IgG in E and H. Bar in A,  10 p. 
587  Romagnoli et al. Figure  4.  Double-staining of transferrin and Ii in COS 7.2 cells expressing hlip31. Cells were pulsed for 45 rain at 37~  with iron-saturated human 
transferrin (20 t~g/ml), then either fixed (A and B) or washed, and normal serum-containing medium added to chase the human transfen'in with bovine 
transferrin (C and D). After fixation, cells were permeabilized and stained with FITC-labeled sheep antibodies to human transferrin (44) (A and C) 
and the mAb LN2 (/3 and D). TRITC-labeled anti-mouse IgG antibodies were used to detect the anti-Ii antibody (B and D). 
sorting compartment between TGN  and late endosomes/ 
prdysosomes. Neither reagent showed significant colocali- 
zation with Ii in macrosomes in these cells. Additional staining 
revealed that Ii macrosomes contain a very smaU but detect- 
able amount of proteolytic enzymes such as cathepsin D, which 
has been recently described as trafficking through early en- 
dosomes (46),  but lack significant amounts of MHC class 
I molecules (data not shown), which segregate from MHC 
Figure  5.  Localization of internalized influenza virus in Ii macrosomes.  48 h after transfection,  COS 7.2 cells were incubated with heat-inactivated 
influenza virus in the presence of protein synthesis inhibitors as described.  After fixation and permeabilization, hemagghtinin was detected with the 
mAb Y8-10C2 (45) (,4) and mlip41 with the mAb In-1 (B). TRITC-labeled anti-mouse IgG and FITC-labded  anti-rat IgG were used in the second step. 
588  Ii and MHC Class II Transport into Early and Late Endocytic Compartments Figure  6.  Double-staining ofli and prelysosomal/lysosomal  markers in COS 7.2 cells expressing hlip31. Transfected cells preloaded with TKIC-OVA 
(pulse 3 h, chase 20 h) (A) were fixed, permeabilized, and stained with anti-Ii mAb VIC-Y1. FITC-iabeled anti-mouse IgG was used in the second 
step to reveal Ii staining (B). Endogenous lamp-l, a marker of prelysosomes and lysosomes, was detected with the mAb BB6 and TKITC-hbeled anti-mouse 
IgG for the second step (C). After blocking with mouse IgG, Ii was detected with directly fluoresceinated VIC-Y1 (D). Ii macrosomes are BB6-negative. 
(Arrows) Positions of Ii-positive, lamp-l-negative macrosomes  (C and D). 
class II in the TGN  (8).  The accumulation in macrosomes 
of endocytic tracers such as FITC-OVA occurred readily at 
20~  (data not shown), again consistent with this compart- 
ment representing altered early endosomes (47). 
To identify mature lysosomes, cells were incubated in la- 
beled dextran or OVA for several  hours, then washed,  and 
the internalized label chased for 20-24 h to permit complete 
transport  to and accumulation in terminal lysosomes. Fig. 
6, A  and B  show that Ii does not colocalize with the lyso- 
somes marked by this method. Similar results were obtained 
for cells coexpressing MHC class II and Ii (data not shown). 
High  lamp-1  content  is  characteristic  of both  late  endo- 
somes/prelysosomes, and lysosomes (35, 48). Consistent with 
this, COS cells labeled with dextran as just described, then 
stained for endogenous lamp-1 show a significant overlap in 
location of the two markers, although a cohort of lamp-l-posi- 
tive,  tracer-negative  vesicles  is  always  observed  (data  not 
shown).  Lamp-1 was not found in Ii macrosomes (Fig.  6, 
C  and D, arrows), consistent with their characterization  as 
modified early endosomes. There was clear colocalization in 
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smaller vesicles of lamp-1 with Ii detected using a cytoplasmic 
tail specific reagent (VIC-YI), which will be discussed below. 
Ii-Macrosoraes Show a Markedly Decreased Rate of Transport 
of  Luraenal and Membrane-associated  Material to Later Endocytic 
Compartments.  The morphologic modification of early en- 
dosomes by Ii prompted us to examine whether the transit 
of molecules through this compartment was also altered by 
the presence of Ii. COS cells either possessing or lacking Ii 
macrosomes were examined for the transfer of OVA through 
this early compartment to later stages in the endocytic pathway. 
Transfected COS cells were first labeled with TRITC-OVA 
by incubation for 5 h, followed by a chase for 24 h, resulting 
in accumulation of the label in lamp-1 + lysosomes. When 
COS cells expressing MHC class II only were incubated in 
FITC-OVA for 1 h, washed, and reincubated for 1, 6, or 24 h 
at 37~  the FITC-OVA began to show colocalization with 
the TRITC-OVA-marked lysosomes as early as 1 h of chase, 
with further increases over time (Fig. 7, A-C).  In contrast, 
COS cells also expressing hIip31,  although demonstrating 
a large accumulation of FITC-OVA in macrosomes, did not Figure  7.  Rate of transport of OVA to lysosomes in COS 
7.2 cells expressing either AatbA~ (A-C) or hlip31 (D-F). 
COS 7.2 cells were preloaded with TILITC-OVA in condi- 
tiom allowing lysosome labeling.  Cells were then exposed 
to FITC-OVA at 1 mg/ml for 1 h and reincubated in normal 
medium at 37"C for 1 h (A and D), 6 h (B and E), and 24 h 
(C and F). Only transfected  cells showing macrosomes  by 
phase contrast were included in this analysis. 
show significant colocalization of this marker with TKITC- 
OVA  at  the  1-  or  6-h  time  points.  Transfer to  lysosomes 
was observed after an overnight chase (Fig. 7, D-F). At this 
late  time,  FITC-OVA  was  also  depleted  from  the  macro- 
somes. This is in contrast to transferriffs rapid entry into and 
exit from macrosomes, indicating that the Ii-induced altera- 
tion in flow selectively  involves  antegrade,  not retrograde, 
movement. 
A modification of transport  through early endosomes was 
also observed if cells were cotransfected with Ii and lamp-1. 
In cells expressing high levels of lamp-1 molecules, a fraction 
reaches the plasma membrane and then undergoes rapid en- 
Figure  8.  Colocalization of human hmp-1 and hlip31 in Ii-macrosomes. COS 7.2 cells expressing human lamp-1 and hlip31 were fixed and permeabi- 
lized. Human lamp-1 was specifically detected with the mAb HSGll. TgITC-labded anti-mouse IgG were used in the second step (A). After blocking 
free binding sites with mouse IgG, Ii was detected with directly fluoresceinated  VIC-Y1  (B). 
590  Ii and MHC Class II Transport into Early and Late Endocytic Compartments Figure 9.  Different  forms  of Ii are present in distinct 
vesicular  structures,  mIip41-expressing  cells  were  double- 
stained with the mAbs P4H5 (A) and In-1 (B). (Arrow) 
In-1 +/P4H5- vesicle.  In cells  coexpressing  AolbAB  b and 
hlip31 and grown with (E and F) or without (C and D) 
leupeptin, Ii was detected  with the mAb LN2 (C and E) 
and ActbABb  with the mAb M5/114 (D and F). 
docytosis and movement through the endocytic pathway to 
lysosomes (35, 48). In contrast to the results described above 
(Fig. 2 A) for cells transfected with human lamp-1 only, coex- 
pression of hlip31 with human lamp-1 (Fig.  8 A) resulted 
in lamp-1 accumulation in the Ii-containing macrosomal struc- 
tures  (Fig.  8  B).  This indicates that  egress of membrane- 
associated proteins from this site to late endosomes/lysosomes 
is also  retarded. 
Distinct Populations of Endocytic Vesicles Contain Epitopically 
Intact  and  COOH  Terminally  Degraded Ii.  The activity of 
MHC class II molecules in antigen presentation requires the 
binding of processed antigenic peptides, an event that is de- 
pendent on the removal of (intact) Ii from the MHC class 
II molecule (24). Ii is known from metabolic labeling studies 
to undergo progressive proteolytic cleavage  after transport 
from the late Golgi (49, 50), and intracellular peptide binding 
to MHC class II is only seen after such cleavage has occurred 
(11). Recent data suggest that processing of antigen in the 
class  II  pathway may occur most efficiently in  late endo- 
somes/lysosomes (51), and the bulk of MHC class II in EBV- 
transformed cells is found in vesicles with the characteristics 
of late endosomes/prelysosomes (9). We therefore carefully 
examined the transfected COS cells for the presence of MHC 
class II and Ii in vesicular structures other than modified early 
endosomes. In some cells coexpressing Ii and MHC class II, 
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we noted not only macrosomes staining for both proteins, 
but also vesicles positive for MHC class II but failing to stain 
with LN2,  a mAb directed against the lumenal part of Ii. 
Because the detection of MHC class II molecules in vesicular 
structures in COS cells is dependent on Ii coexpression, and 
it is known that Ii is proteolyticaUy processed from the COOH 
terminus (lumenal segment) when complexed with MHC 
class II molecules (50),  it thus seemed likely that the Ii in 
these class II-positive vesicles had been posttranslationally 
altered or degraded. 
To examine this issue,  we took advantage of two sets of 
monoclonal anti-Ii Abs: (a) P4HS, which reacts with the lu- 
menal region of mli (52),  and In-l, which reacts with the 
cytoplasmic region of mli (21);  and (b) LN2,  which reacts 
with the COOH-terminal, lumenal region of hli (39),  and 
VIC-Y1,  which reacts with the NH2-terminal, cytoplasmic 
region of hli (38).  After transfection of either mlip31 (data 
not shown) or mlip41, vesicles failing to stain with the lumen- 
specific  antibody  (Fig.  9  A)  but  reactive  with  the  anti- 
cytoplasmic tail reagent (Fig.  9 B) were observed,  though 
not the converse. Likewise, in cells expressing hlip31, NH~- 
terminal epitope-positive but COOH-terminal epitope-nega- 
tive vesicles were found (data not shown). In transfectants 
coexpressing hlip31  and AolbAB  b, class II and Ii colocalize 
in  all  vesicles  when  examined using  the  antibody to  the Figure  10.  Characterization of hlip31All  + vesicles. (A and B) COS 7.2 cells expressing  hlip31A11 were pulsed for 30 min at 37~  with iron- 
saturated human transferrin (20/zg/ml). Cells were then fixed, permeabilized, and stained with FITC-labeled sheep antibodies to human transferrin 
(.4) and the mAb VIC-Y1 (B). TRITC-labeled anti-mouse IgG Abs were used in the second step. (Arrow) Single transferrin and Ii-containing vesicle. 
(C and D) hlip31A11-expressing  cells were doubh-stained with the mAb BB6  (C) and the mAb VIC-Y1  (D). 
NH2-terminal cytoplasmic tail (Fig. 9, C  and D).  However, 
a cohort of vesicles lacking staining with the anti-Ii lumen- 
specific antibody (Fig.  9  C), but containing MHC  class  II 
(Fig. 9 D) was found. As seen in cells coexpressing AcxbAB  b 
and hlip31, cells with AoLbAfl  b and either mlip31 or mlip41 
showed that all class II-containing vesicles had Ii as assessed 
with an antibody to the cytoplasmic tail, but a subset of vesicles 
with dass II lacked reactivity with the anti-Ii lumenal epi- 
tope antibody (data  not  shown). 
Cells transfected with hlip31 plus AabAfl  b and grown in 
the presence of leupeptin, an inhibitor of one of the enzymes 
(cathepsin B) believed responsible for the intracellular pro- 
teolysis of Ii (50), showed a complete overlap of staining with 
anti-dass II and the anti-Ii antibody to the lumenal epitope 
(Fig. 9, E  and F). This confirms that the difference between 
the two sets of vesicles described above is the extent of pro- 
teolytic cleavage of the Ii in its COOH-terminal  (lumenal) 
region. 
Characterization of Vesicles Containing Ii with N- or C-Region 
Truncations.  The vesicles containing LN2 (lumenal epitope)- 
negative Ii were frequently smalhr than those containing Ii 
that stained with LN2. This, plus the discrete nature of the 
difference in staining corresponding to individual vesicles, im- 
plied that the structures containing cleaved Ii were a part of 
the endocytic pathway distinct from the modified early en- 
dosomes. Antibody to the hli cytoplasmic tail stained a sub- 
population of smaller vesicles that also could be stained by 
anti-lamp-1  (Fig.  6,  C  and D).  Furthermore,  this reagent 
identified a cohort of vesicles that was not readily accessible 
to transferrin,  and that was not accessible  to OVA at 20~ 
(data  not shown).  Because no localization of Ii or class  II 
was seen in terminal lysosomes (see above), these data iden- 
tify  the  vesicles  containing  cleaved  Ii  as  late  endosomes/ 
prelysosomes, the same compartment shown to be the site 
of the highest steady state level of MHC  class  II in trans- 
formed B  cells (9).  When  leupeptin was added to prevent 
destruction of the COOH-terminal  part of Ii, some of the 
vesicles containing Ii reactive with antibody to the lumenal 
segment were not readily accessible to transferrin (data not 
shown). This suggests that the COOH-terminal cleavage ac- 
companies, but does not control, movement from early to 
late endocytic compartments. 
Another form of Ii was also observed in this late compart- 
ment. hlip31 with a deletion of the residues 2-11 of the cy- 
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and was found in smaller vesicles. These vesicles were largely 
inaccessible to transferrin, costained with lamp-1 (Fig.  10), 
and were not accessible to fluid phase markers at 20~  (data 
not shown). Thus, they have the same properties as the vesicles 
with COOH terminally cleaved Ii found after expression of 
the full-length Ii (Iip31). The bulk of coexpressed MHC class 
II colocalizes in these late endosomes/prelysosomes (data not 
shown), replicating the distribution seen in transformed B 
cells that are efficient at antigen processing and presentation 
via class II molecules. 
Discussion 
The observations  that  Ii possesses  a  cytoplasmic signal 
responsible for transport to endocytic structures and that MHC 
class II molecules localize in endocytic compartments when 
coexpressed with Ii containing this cytoplasmic signal has 
led to a model in which the movement of MHC class II to 
the endocytic pathway for peptide capture is mediated by as- 
sociation with Ii (10, 29, 30). The present report confirms 
and extends these initial observations, demonstrating that such 
Ii-dependent deviation of MHC class II from the default ex- 
ocytic pathway is observed in other cell types, with other 
MHC class II isotypes, and for various forms of Ii.  Endo- 
cytic localization is observed for Ii alone or in association 
with complete ot/B dimers, indicating that MHC class II is 
not essential to the formation of the targeting signal, although 
differences in the localization pattern seen in the presence and 
absence of MHC class II that suggest its presence can modify 
the localization properties of Ii (10, 30). These experiments 
also provide the first direct demonstration that the p41 form 
of Ii can independently enter the endocytic pathway and that 
it can direct class II to this site. Whether subtle differences 
exist in the rate of movement, site of accumulation, or rate 
of dissociation of Iip31-class II vs. Iip41-class  II complexes 
remains to be determined. Such differences might explain the 
distinct effects of these two forms of Ii in presentation of 
certain antigens (53). 
Previous studies on the intracellular localization of Ii have 
not examined the state of this molecule in the various com- 
partments in which it can be detected. This is a critical issue, 
as it is clear that proteolytic modification of Ii is essential 
to the proper function of MHC class II molecules in antigen 
presentation. We demonstrate here that Ii present in early 
endocytic vesicles is largely intact. Most Ii molecules in late 
endosomes/prelysosomes have undergone lumenal cleavage 
by the time they have accumulated in this compartment. 
Studies with the protease inhibitor leupeptin suggest that 
this cleavage may be a consequence of proteolytic activity 
in this compartment, rather than a necessary prelude to move- 
ment to this site. The MHC class II molecules in late endo- 
somes/prelysosomes are in any case dearly associated  with 
a form of Ii that has undergone initial cleavage in the region 
most likely to play a major role in regulating peptide binding, 
thus providing them with the opportunity to initiate pep- 
tide acquisition. 
Under conditions of high Ii expression, class II and intact 
Ii colocalized in a transferrin-accessible compartment with 
additional characteristics of early endosomes, implying that 
this was the site of entry into the endosomal pathway, as sug- 
gested previously by CressweU (54).  It is unlikely that ac- 
cumulation of class II and Ii in early endosomes was the re- 
sult of "spiUover" into this compartment after saturation of 
a transport system that normally results in direct movement 
from the trans-Golgi to late endosomes/prelysosomes (9, 30). 
This latter model would predict that all transfectants would 
show  class  II  localization  in  lamp-l-positive,  transferrin- 
inaccessible  vesicles as a consequence of "correct" transport 
before overloading of this putative transport pathway. Yet 
in cells with large numbers of macrosomes, such late endo- 
cytic localization was rarely seen, arguing against an "overflow" 
explanation of our observations. 
The accumulation of human lamp-1 in early endosomes 
when coexpressed with Ii, and the failure to visualize this 
molecule in such vesicles in the absence of Ii, is best explained 
by a rapid flux through and low steady state concentration 
of human lamp-1 in early endosomes when expressed alone. 
The detection of class II and Ii in late but not early endo- 
somes in the presence of moderate levels of Ii is thus also 
likely to result from the rapid passage of MHC class II-Ii 
complexes through the early endocytic compartment and the 
slower egress of these molecules from late endosomes/prely- 
sosomes under these conditions. These findings emphasize 
the distinction between the compartments a molecule may 
transiently access during intracellular movement, and the sites 
of high  steady state accumulation readily seen by immu- 
nofluorescence or electron microscopy. 
A  striking  and previously unrecognized property of Ii 
documented here is its ability to actively alter both the struc- 
ture and transport properties of the early endocytic compart- 
ment. Macrocytic vesicles were formed in COS cells expressing 
Ii with an intact cytoplasmic tail in the absence or, in certain 
cases, the presence of MHC class II. Transferrin entry into 
and exit from macrosomes occurred rapidly, indicating that 
vesicular movement from the cell membrane to early endo- 
somes and from these endosomes back to the membrane was 
largely unaffected by the introduction of Ii. However, ante- 
grade  movement  to  later  endocytic  compartments  was 
markedly slowed as assessed fluid phase marker studies, and 
this diminished rate of transport also seemed to affect mem- 
brane proteins moving through this compartment, for ex- 
ample, lamp-1 overproduced after gene transfer. 
Is this effect of Ii on endocytic structure and function an 
artifact of the high protein expression level of the COS cell 
model, or does it reflect an important biological property 
of Ii? High level expression in COS cells of various proteins 
destined for default exocytic movement fails to cause such 
alterations. Furthermore, overexpression of other molecules 
normally accumulating in late endocytic compartments but 
trafficking through early endosomes (e.g., lamp-l) also fails 
to induce these modifications, providing evidence that non- 
specific protein overloading of endosomes is not the cause 
of this effect. An Ii mutant lacking NH2-terminal residues 
2-11 also does not induce macrosomes, despite being trans- 
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cally truncated form of Ii is synthesized at the same rate as 
intact Ii, these data indicate that saturation of a proteolytic 
process required for Ii cleavage that protects the early endo- 
cytic compartment from disruption cannot explain the present 
observations. Furthermore, the observation that removal of 
the highly conserved residues 2-11 from the NH2 terminus 
of Ii prevents macrosome formation and early endosomal reten- 
tion is consistent with the capacity to alter endosomal func- 
tion being an important property of Ii.  This region is not 
essential to endosomal targeting, as the A2-11 form of Ii still 
deviates from the default pathway to accumulate in late en- 
dosomes. These residues of the NH2 terminus of Ii are well 
conserved in evolution (29). Such conservation in the absence 
of its requirement for endosomal targeting suggests that this 
sequence has an additional role, which may be to regulate 
transport of MHC class II and other proteins from early to 
late endosomes. 
The extent of Ii expression does dictate the size and number 
of the altered early endosomes and coexpression of MHC class 
II reduces the extent of enlargement and/or the number of 
such structures. Typical MHC class II-positive hematopoi- 
etic cells produce Ii in molar excess over MHC class II (23, 
55) and flee Ii is present in such cells. However, in both human 
cells expressing Ii but lacking class II (23, 30) or class II-nega- 
tive mouse cells transfected with an Ii expression construct 
(56), only a small fraction of Ii (perhaps 5%) leaves the ElK. 
In CV-1 cells transfected with the hlip31 construct used in 
the present experiment, a larger fraction of the expressed Ii 
(15%) develops N-linked glycans resistant to endoglycosidase 
H digestion (29), indicating passage through the medial Golgi. 
These results suggest that dramatic alterations in early endo- 
some structure and function would be seen only in cells with 
very high Ii synthetic rates in excess of class II production, 
consistent with the failure to observe macrosome-like struc- 
tures in most class II-expressing cells. Freshly isolated Lang- 
erhans cells have an extraordinarily high rate of Ii and MHC 
class II biosynthesis (57) and significant surface Ii expression 
(58). Associated with this high rate synthesis is the presence 
of large lucent acidic vesicles with the characteristics of early 
endosomes (59). Although no direct evidence establishes that 
the extremely high rate of Ii synthesis is responsible for these 
structures in Langerhans cells, the COS data suggest this pos- 
sibility,  which is consistent with the loss of these structures 
upon culture as Ii levels decline. It is possible that the levels 
of Ii seen in other class II-expressing cells such as B lympho- 
cytes may result in more subtle changes in endosomal func- 
tion. In either case, these changes might enhance class II pre- 
sentation by preventing excessive degradation of some antigens 
or by increasing the opportunity for endosomal vesicle fu- 
sion, assuring more access of newly synthesized class II to 
endocytosed antigen. 
The capacity of Ii to alter early endosomal structure and 
activity raises the question as to the molecular mechanism 
by which this occurs. Two distinct possibilities  can be con- 
sidered. Ii is known to undergo multimerization and when 
free of MHC class II, higher order aggregation (23).  Thus, 
a physical change in membrane structure due to the creation 
of large sheets of Ii could interfere with membrane trafficking, 
leading to the gross enlargement that characterizes macro- 
somes. Alternatively, Ii might contain specific structural fea- 
tures that interact with the machinery responsible for inter- 
compartmental vesicular tra~c, changing the formation or 
movement of vesicles, or the fusion competence of vesicular 
structures. The recent reports that both levels of expression 
of and ligand interaction with ERD-2 (60)  or ELP-1  (61) 
control of the rate of retrograde traffic between the inter- 
mediate compartment (cis-Golgi network) and EIK provides 
an intriguing model for active regulation of intercompart- 
mental transit. Thus, further study of Ii might provide new 
insights into the biochemical regulation of intracellular trans- 
port in general, and the ways in which differentiated cells 
modify the basic transport machinery for specialized functions. 
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